Adorable, April Rose M.
HRN: 21-84-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/10/2022
12/19/2022
PO
6 Ml
TID
BLOODY DIARRHEA
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes